High Flow Nasal Cannula Is Appropriate Alternative for Stabilization of Very Premature Infants: A Prospective Observational Study — SIMPLSAFE  

Premature; Infant Clinical Trial

Official title: High Flow Nasal Cannula Is Appropriate Alternative for Stabilization of Very Premature Infants: A Prospective Observational Study

Status Completed

Clinical Trial Summary

A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Premature Birth
• Premature; Infant

• NCT number: NCT06458582
• Study type: Interventional
• Source: Charles University, Czech Republic
• Status: Completed
• Phase: N/A
• Start date: February 1, 2021
• Completion date: December 31, 2022